| Active substance | Finerenone |
| Holder | Bayer AG |
| Status | Running |
| Indication | Chronic Kidney Disease in pediatric patients who participated in the FIONA open label extension study. |
| Public documents | Approbation |
| Last update | 25/03/2026 |
Finerenone
Last updated on